Primary Prevention of Cardiovascular and Heart Failure Events With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Their Combination in Type 2 Diabetes (2022)

First Author: Rutter M
Attributed to:  MICA: Health e-Research Centre funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.2337/figshare.18286751

Publication URI: http://dx.doi.org/10.2337/figshare.18286751

Type: Other